Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.76T | 3.12T | 2.72T | 2.71T | 2.63T |
Gross Profit | 3.78T | 2.97T | 2.72T | 2.71T | 2.63T |
EBITDA | 1.40T | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 885.43B | 678.99B | 555.53B | 530.48B | 471.02B |
Balance Sheet | |||||
Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Cash, Cash Equivalents and Short-Term Investments | 10.00T> | 71.17T | 67.15T | 51.36T | 74.42T |
Total Debt | 60.89T | 20.84T | 19.60T | 20.90T | 21.64T |
Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Stockholders Equity | 10.44T | 10.23T | 9.13T | 9.08T | 9.26T |
Cash Flow | |||||
Free Cash Flow | -4.17T | 1.63T | 8.68T | 4.78T | 16.40T |
Operating Cash Flow | -3.82T | 1.88T | 8.87T | 4.92T | 16.61T |
Investing Cash Flow | 3.79T | 1.98T | 6.61T | -1.86T | -9.76T |
Financing Cash Flow | -299.03B | -230.99B | -611.14B | -522.06B | 40.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $73.48B | 13.11 | 11.15% | 3.45% | 3.07% | 19.01% | |
77 Outperform | $121.79B | 19.77 | 17.89% | 0.70% | 22.15% | 12.13% | |
74 Outperform | $67.16B | 9.42 | 20.65% | 8.23% | -6.74% | 5.13% | |
73 Outperform | $71.30B | 11.33 | 11.50% | 4.37% | 2.19% | 34.00% | |
65 Neutral | $69.35B | 12.10 | 8.45% | 2.31% | 13.63% | 27.77% | |
63 Neutral | $55.80B | 12.56 | 0.10% | 4.88% | -27.31% | ― | |
58 Neutral | $12.55B | 5.33 | -2.71% | 5.27% | 5.88% | -56.03% |